SRPT
Sarepta Therapeutics,, Inc. Common StockstockNASDAQ
At CloseOct 30, 2026 4:33:30 PM EDT
18.80USD-2.236%(-0.43)1,318,156
Pre-marketOct 30, 2026 10:29:58 AM EDT
18.68USD-2.860%(-0.55)
SRPT Financials
In Q2 FY 2026 (ended ), Sarepta Therapeutics,, Inc. Common Stock (SRPT) reported revenue of $401.25M, net income of −$4.89M, operating cash flow of $197.07M, and assets of $3.19B.
Loading financial flows…
